Covered recipient · General Payments record
JOYCE H HOOT
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$772.73
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $439.13 | 15 |
| Education | $108.44 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $220.49 | 10 |
| Janssen Biotech, Inc. | $185.93 | 2 |
| Lilly USA, LLC | $60.78 | 2 |
| E.R. Squibb & Sons, L.L.C. | $33.12 | 1 |
| GENZYME CORPORATION | $25.45 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.67 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103937167 | CMS |
| ABBVIE INC. | $9.63 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103937169 | CMS |
| ABBVIE INC. | $8.45 | 03/28/2024 | Education | Undisputed | 01/23/2026 | 1104196390 | CMS |
| ABBVIE INC. | $27.33 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103937171 | CMS |
| ABBVIE INC. | $33.44 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103937173 | CMS |
| ABBVIE INC. | $27.94 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103937175 | CMS |
| ABBVIE INC. | $8.28 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103937177 | CMS |
| ABBVIE INC. | $22.62 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103937179 | CMS |
| ABBVIE INC. | $25.37 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103937181 | CMS |
| ABBVIE INC. | $32.76 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103937183 | CMS |
| E.R. Squibb & Sons, L.L.C. | $33.12 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101312615 | CMS |
| GENZYME CORPORATION | $25.45 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139870949 | CMS |
| Janssen Biotech, Inc. | $99.99 | 04/16/2024 | Education | Undisputed | 01/23/2026 | 1078592162 | CMS |
| Janssen Biotech, Inc. | $85.94 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078592004 | CMS |
| Lilly USA, LLC | $32.66 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135083600 | CMS |
| Lilly USA, LLC | $28.12 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135096250 | CMS |
| Novartis Pharmaceuticals Corporation | $21.80 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086960965 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.